AIM

Aim Immunotech
$0.25
+$0.00 (+0.4%)Jul 27, 2026
0.4PoorMoatMint rating

MoatMint rates Aim Immunotech (AIM) 0.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.0 out of 10.

Key metrics

The numbers that frame AIM today
Market cap
$3.64M
P/E (TTM)
-0.3
EV / FCF
-0.2
Gross margin
-29.8%
EV / Sales
25.5
ROIC
667.8%
Div yield
0%
Debt / equity
2.2
52wk Low
$0.21
52wk High
$20.35

AIM stock rating

How AIM scores on quality, value, growth, momentum and financial health
0.4out of 10
Low overallNeutral business, expensive priceTop 96% of ~5,000 US stocks
QualityPoor0.0/10
GrowthGreat10/10
MomentumPoor0.3/10
ValuePoor0.1/10
Financial HealthPoor0.7/10

Growth

Revenue and earnings trend for AIM
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AIM
Is Aim Immunotech a good buy?
No. Aim Immunotech has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aim Immunotech is selling at a very high price.
What is the market capitalization of AIM?
Aim Immunotech's market capitalization is $3.64M.
What is the P/E ratio for AIM stock?
Aim Immunotech's current P/E ratio is -0.3.
What is the 52-week high for AIM stock?
The 52-week high for Aim Immunotech is $20.35. The current close of $0.25 is 98.8% below that high.
What is the 52-week low for AIM stock?
The 52-week low for Aim Immunotech is $0.21. The current close of $0.25 is 19% above that low.
Does AIM stock pay dividends?
Aim Immunotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AIM?
Aim Immunotech's Debt / Equity ratio is 2.15.